Ibrutinib Capsules and Insulin aspart, recombinant Subcutaneous
Determining the interaction of Ibrutinib Capsules and Insulin aspart, recombinant Subcutaneous and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: ibrutinib
Brand name: Imbruvica
Synonyms: Ibrutinib
Generic Name: insulin aspart
Brand name: Fiasp, NovoLog, NovoLog FlexPen, NovoLog PenFill, NovoLOG FlexTouch, Fiasp PenFill, Fiasp FlexTouch
Synonyms: Insulin aspart, Insulin Aspart
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Ibrutinib Capsules-Insulin degludec
- Ibrutinib Capsules-Insulin Degludec (U-100) Prefilled Pens
- Ibrutinib Capsules-Insulin Degludec (U-100) Vials
- Ibrutinib Capsules-Insulin Degludec (U-200) Prefilled Pens
- Ibrutinib Capsules-Insulin degludec and liraglutide
- Ibrutinib Capsules-Insulin degludec and liraglutide Subcutaneous
- Insulin aspart, recombinant Subcutaneous-Ibrutinib Tablets
- Insulin aspart, recombinant Subcutaneous-Ibu
- Insulin aspart, recombinant Subcutaneous-IBU Tablets
- Insulin aspart, recombinant Subcutaneous-Ibu-2
- Insulin aspart, recombinant Subcutaneous-Ibu-200
- Insulin aspart, recombinant Subcutaneous-Ibu-4